These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19378675)

  • 1. First-in-man (FIM) study of the Stentys bifurcation stent--30 days results.
    Verheye S; Grube E; Ramcharitar S; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Serruys PW; van Geuns RJ
    EuroIntervention; 2009 Mar; 4(5):566-71. PubMed ID: 19378675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions.
    Verheye S; Ramcharitar S; Grube E; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Spaargaren R; Serruys PW; García-García HM; van Geuns RJ
    EuroIntervention; 2011 Sep; 7(5):580-7. PubMed ID: 21930462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study.
    Amoroso G; van Geuns RJ; Spaulding C; Manzo-Silberman S; Hauptmann KE; Spaargaren R; García-García HM; Serruys PW; Verheye S
    EuroIntervention; 2011 Aug; 7(4):428-36. PubMed ID: 21764660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting.
    Lu H; IJsselmuiden AJ; Grundeken MJ; Nassif M; de Vries AG; Weevers A; Scholte M; Spaargaren R; Wykrzykowska JJ; Tijssen JG; de Winter RJ; Koch KT
    EuroIntervention; 2016 Mar; 11(12):1341-5. PubMed ID: 25983027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry.
    Agostoni P; Foley D; Lesiak M; Belkacemi A; Dens J; Kumsars I; Scott B; Oemrawsingh P; Dubois C; Garcia E; Lefèvre T; Stella PR
    EuroIntervention; 2012 Mar; 7(11):1293-300. PubMed ID: 22433192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
    Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
    EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis.
    Zamani P; Kinlay S
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):202-12. PubMed ID: 20824754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
    EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry.
    Magro M; Girasis C; Bartorelli AL; Tarantini G; Russo F; Trabattoni D; D'Amico G; Galli M; Gómez Juame A; de Sousa Almeida M; Simsek C; Foley D; Sonck J; Lesiak M; Kayaert P; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Mar; 8(11):1259-69. PubMed ID: 23538155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations.
    Kyono H; Guagliumi G; Sirbu V; Rosenthal N; Tahara S; Musumeci G; Trivisonno A; Bezerra HG; Costa MA
    EuroIntervention; 2010 May; 6(1):69-77. PubMed ID: 20542800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: final results of the AGILITY trial.
    Weisz G; Metzger DC; Liberman HA; O'Shaughnessy CD; Douglas JS; Turco MA; Mehran R; Gershony G; Leon MB; Moses JW
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):352-9. PubMed ID: 22927100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience.
    Burzotta F; Gwon HC; Hahn JY; Romagnoli E; Choi JH; Trani C; Colombo A
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):75-82. PubMed ID: 17585382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial.
    Costa RA; Abizaid A; Abizaid AS; Garcia del Blanco B; Berland J; Petrov I; Brenot P; van Guens RJ; Royer T; Rubino P; Lesiak M; Fajadet J;
    EuroIntervention; 2012 Mar; 7(11):1301-9. PubMed ID: 22433193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial.
    Mathey DG; Wendig I; Boxberger M; Bonaventura K; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K61-5. PubMed ID: 22027730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt - the MATISSE study.
    Cortese B; Montefusco A; D'Ascenzo F; La Manna A; Andò G; Bisceglia T; Secco GG; Meyer-Gessner M; Wańha W; Sganzerla P; Napodano M; Di Palma G; Latini RA; Tamburino C; Orrego PS; Baumbach A
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):831-836. PubMed ID: 29661597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.